临床试验的途径。
Gateways to clinical trials.
作者信息
Tomillero A, Moral M A
出版信息
Methods Find Exp Clin Pharmacol. 2008 Oct;30(8):643-72.
Gateways to clinical trials is a guide to the most recent trials in current literature and congresses. The data in the following tables has been retrieved from the Clinical Trials Knowledge Area of Prous Science Integrity(R), the drug discovery and development portal, http://integrity.prous.com. This issue focuses on the following selection of drugs: (+)-Dapoxetine hydrochloride, (S)-Tenatoprazole sodium salt monohydrate 19-28z, Acotiamide hydrochloride hydrate, ADV-TK, AE-37, Aflibercept, Albinterferon alfa-2b, Aliskiren fumarate, Asenapine maleate, Axitinib; Bavituximab, Becatecarin, beta-1,3/1,6-Glucan, Bevacizumab, Bremelanotide; Calcipotriol/betamethasone dipropionate, Casopitant mesylate, Catumaxomab, CDX-110, Cediranib, CMD-193, Cositecan; Darinaparsin, Denosumab, DP-b99, Duloxetine hydrochloride; E75, Ecogramostim, Elacytarabine, EMD-273063, EndoTAG-1, Enzastaurin hydrochloride, Eplerenone, Eribulin mesilate, Esomeprazole magnesium, Etravirine, Everolimus, Ezetimibe; Faropenem daloxate, Febuxostat, Fenretinide; Ghrelin (human); I-131 ch-TNT-1/B, I-131-3F8, Iclaprim, Iguratimod, Iloperidone, Imatinib mesylate, Inalimarev/Falimarev, Indacaterol, Ipilimumab, Iratumumab, Ispinesib mesylate, Ixabepilone; Lapatinib ditosylate, Laquinimod sodium, Larotaxel dehydrate, Linezolid, LOR-2040; Mapatumumab, MKC-1, Motesanib diphosphate, Mycophenolic acid sodium salt; NK-012; Olanzapine pamoate, Oncolytic HSV, Ortataxel; Paclitaxel nanoparticles, Paclitaxel poliglumex, Paliperidone palmitate, Panitumumab, Patupilone, PCV-9, Pegfilgrastim, Peginterferon alfa-2a, Peginterferon alfa-2b, Pertuzumab, Picoplatin, Pimavanserin tartrate, Pimecrolimus, Plerixafor hydrochloride, PM-02734, Poly I:CLC, PR1, Prasugrel, Pregabalin, Progesterone caproate, Prucalopride, Pumosetrag hydrochloride; RAV-12, RB-006, RB-007, Recombinant human erythropoietin alfa, Rimonabant, Romidepsin; SAR-109659, Satraplatin, Sodium butyrate; Tadalafil, Talampanel, Tanespimycin, Tarenflurbil, Tariquidar, Taurine, Tecovirimat, Telatinib, Telavancin hydrochloride, Telcagepant, Terameprocol, Tesofensine, Tetrodotoxin, Tezampanel, Tipifarnib, TPI-287, Tremelimumab; Valspodar, Vatalanib succinate, VCL-CB01, vCP1452, Vorinostat; XL-228; Ziprasidone hydrochloride.
临床试验指南是获取当前文献和会议中最新试验的指南。以下表格中的数据取自药物研发门户网站Prous Science Integrity(R)的临床试验知识领域，网址为http://integrity.prous.com。本期重点关注以下几种药物：（+）-盐酸达泊西汀、（S）-一水合替那拉唑钠盐19 - 28z、盐酸阿考替胺水合物、ADV - TK、AE - 37、阿柏西普、重组人干扰素α-2b、阿利吉仑富马酸盐、马来酸阿塞那平、阿昔替尼；巴维昔单抗、贝卡替林、β-1,3/1,6-葡聚糖、贝伐单抗、布雷美拉诺肽；卡泊三醇/倍他米松二丙酸酯、甲磺酸卡索匹坦、卡妥索单抗、CDX - 110、西地尼布、CMD - 193、考西他滨；达利珠单抗、地诺单抗、DP - b99、盐酸度洛西汀；E75、生态粒细胞刺激因子、依拉胞苷、EMD - 273063、EndoTAG - 1、盐酸恩杂鲁胺、依普利酮、甲磺酸艾瑞布林、埃索美拉唑镁、依曲韦林、依维莫司、依折麦布；法罗培南钠、非布司他、芬维A胺；胃饥饿素（人）；I - 131 ch - TNT - 1/B、I - 131 - 3F8、伊克拉明、艾拉莫德、伊潘立酮、甲磺酸伊马替尼、Inalimarev/Falimarev、茚达特罗、伊匹木单抗、伊拉妥单抗、甲磺酸伊斯平西布、伊沙匹隆；拉帕替尼二对甲苯磺酸盐、拉喹莫德钠、脱水拉罗他赛、利奈唑胺、LOR - 2040；马帕木单抗、MKC - 1、二磷酸莫替沙尼、霉酚酸钠；NK - 012；奥氮平棕榈酸酯、溶瘤性单纯疱疹病毒、奥他赛；紫杉醇纳米粒、聚乙二醇化紫杉醇、帕利哌酮棕榈酸酯、帕尼单抗、帕妥珠单抗、PCV - 9、聚乙二醇非格司亭、聚乙二醇干扰素α-2a、聚乙二醇干扰素α-2b、帕妥珠单抗、匹铂、酒石酸匹美范色林、吡美莫司、盐酸普乐沙福、PM - 02734、聚肌苷酸:聚胞苷酸、PR1、普拉格雷、普瑞巴林、己酸孕酮、普芦卡必利、盐酸普莫西沙；RAV - 12、RB - 006、RB - 007、重组人促红细胞生成素α、利莫那班、罗米地辛；SAR - 109659、沙铂、丁酸钠；他达拉非、他拉喷酯、坦西莫司、塔伦氟比、塔里夸德、牛磺酸、替考韦瑞马特、特拉替尼、盐酸特拉万星、替拉吉泮、特瑞马科、替索芬辛、河豚毒素、替扎喷酯、替匹法尼、TPI - 287、曲美木单抗；伐司朴达、琥珀酸瓦他拉尼、VCL - CB01、vCP1452、伏立诺他；XL - 228；盐酸齐拉西酮。
Zotero 插件